GRM1
protein-codingglutamate metabotropic receptor 1, the group of Protein phosphatase 1 regulatory subunits|Glutamate metabotropic receptors
Gene summary
This gene encodes a metabotropic glutamate receptor that functions by activating phospholipase C. L-glutamate is the major excitatory neurotransmitter in the central nervous system and activates both ionotropic and metabotropic glutamate receptors. Glutamatergic neurotransmission is involved in most aspects of normal brain function and can be perturbed in many neuropathologic conditions. The canonical alpha isoform of the encoded protein is a disulfide-linked homodimer whose activity is mediated by a G-protein-coupled phosphatidylinositol-calcium second messenger system. This gene may be associated with many disease states, including schizophrenia, bipolar disorder, depression, and breast cancer. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, May 2013]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~410.0 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0013905
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0013905
Submitter: Orphanet
Inheritance Pattern: AD
Disease ID:MONDO:0033479
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0013905
Submitter: G2P
Inheritance Pattern: AD
Disease ID:MONDO:0033479
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0013905
Submitter: Labcorp Genetics (formerly Invitae)
Clinical Genomic Database (CGD)
Manifestation: Neurologic
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to GRM1 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_001278064.2. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 9 | 122 | 8 | 139 | ||
| missense | 3 | 1 | 216 | 16 | 236 | |
| nonsense | 2 | 1 | 1 | 4 | ||
| start loss | 0 | |||||
| frameshift | 3 | 6 | 4 | 13 | ||
| splice donor/acceptor (+/-2bp) | 2 | 2 | ||||
| Total | 8 | 8 | 232 | 138 | 8 | 394 |
Highest pathogenic variant AF is 0.000006199874
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_001264993.1 | 8 | MANE Select | |
| Ensembl | ENSP00000282753.1 | 8 | MANE Select | |
| RefSeq | NP_001264994.1 | 8 | Standard | |
| RefSeq | NP_001264995.1 | 8 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Long-term potentiation - Homo sapiens (human)
- Retrograde endocannabinoid signaling - Homo sapiens (human)
- Glutamatergic synapse - Homo sapiens (human)
- Long-term depression - Homo sapiens (human)
- Gap junction - Homo sapiens (human)
Biological Process
- activation of MAPKK activity
- activation of MAPK activity
- G protein-coupled receptor signaling pathway
- G protein-coupled glutamate receptor signaling pathway
- chemical synaptic transmission
Molecular Function
- G protein-coupled receptor activity
- protein binding
- glutamate receptor activity
- G protein-coupled neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration
- G protein-coupled receptor activity involved in regulation of postsynaptic membrane potential
Cellular Component
- nucleus
- plasma membrane
- integral component of plasma membrane
- dendrite
- G protein-coupled receptor dimeric complex
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000361719
- Coding exons
- 8
- Length
- 409953
- Individuals with no LoFs
- 125719
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 29
- Defined
- 125748
- p
- 0.000115
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 2.58 | 475 | 662 | 0.718 | 0.0000394 | 7798 |
| Missense (PolyPhen) | 95 | 249.51 | 0.38074 | 2954 | ||
| Synonymous | -2.83 | 333 | 273 | 1.22 | 0.0000175 | 2449 |
| Loss of Function | 4.47 | 10 | 40.9 | 0.245 | 0.00000232 | 479 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.000062 | 0.000062 | rare |
| Latino/Admixed American | 0.00020 | 0.00020 | rare |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0.00011 | 0.00011 | rare |
| Finnish | 0.00021 | 0.00018 | rare |
| European (Non-Finnish) | 0.00011 | 0.00011 | rare |
| South Asian | 0.000033 | 0.000033 | rare |
| Other | 0.00016 | 0.00016 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: G-protein coupled receptor for glutamate. Ligand binding causes a conformation change that triggers signaling via guanine nucleotide-binding proteins (G proteins) and modulates the activity of down-stream effectors. Signaling activates a phosphatidylinositol-calcium second messenger system. May participate in the central action of glutamate in the CNS, such as long-term potentiation in the hippocampus and long-term depression in the cerebellum. {ECO:0000269|PubMed:24603153, ECO:0000269|PubMed:28886343, ECO:0000269|PubMed:7476890}.;
- Disease
- DISEASE: Spinocerebellar ataxia 44 (SCA44) [MIM:617691]: A form of spinocerebellar ataxia, a clinically and genetically heterogeneous group of cerebellar disorders. Patients show progressive incoordination of gait and often poor coordination of hands, speech and eye movements, due to degeneration of the cerebellum with variable involvement of the brainstem and spinal cord. SCA44 is a slowly progressive, autosomal dominant form. {ECO:0000269|PubMed:28886343}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.186
Intolerance Scores
- LoFtool
- 0.0173
- RVIS EVS
- -0.15
- RVIS percentile EVS
- 42.34
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.775
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |